Might We Come Together on a Paradigm Shift to Manage ICSRs with a Decentralized Data Model?

The current practice of managing and sharing individual case safety reports (ICSRs) across the patient safety ecosystem, established in the 1960s, has become burdened with ICSR duplication and replication and can result in a fragmented understanding of product safety profiles. For this article, we have defined duplication as multiple representations of the same case within the same database and replication as various representations of the same case across numerous databases. Evolving safety regulations and increasing case volumes signal a need for a new path forward that is sustainable and enhances public health. While there is no question that ICSRs are a crucial component of safety surveillance, stakeholders must evaluate their management to ensure they are fit for purpose in a modern ecosystem. This article aims to embark on that path by proposing a conceptual decentralized ICSR management model to facilitate multi-stakeholder collaboration around new working models to mitigate duplication and replication, allow ecosystem stakeholders to access the latest source of truth on demand, facilitate more meaningful safety analysis and interpretation, and ultimately enable a real-time learning healthcare system to improve patient safety and health outcomes. It describes the feasibility analysis results and subsequently conducted proof of concept (PoC) based on a decentralized system architecture supporting such a decentralized model. It outlines considerations, challenges, and opportunities compared with the current state related to case management and signal management processes.

Authors

Institutions

Publication Details

Journal
Drug Safety
Published
2025-03-08
DOI
https://doi.org/10.1007/s40264-025-01539-4
Primary Topic
Electronic Health Records Systems
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Might We Come Together on a Paradigm Shift to Manage ICSRs with a Decentralized Data Model?

Andrew Bate, Dieter Kempf, M. Patel, Michael Gläser et al.
1 links
Drug Safety
Electronic Health Records Systems
article

Might We Come Together on a Paradigm Shift to Manage ICSRs with a Decentralized Data Model?

Andrew Bate, Dieter Kempf, M. Patel, Michael Gläser, L.A. Rollins‐ Smith, Xaymara Roman, Charlotte Artlich
article en

Abstract

The current practice of managing and sharing individual case safety reports (ICSRs) across the patient safety ecosystem, established in the 1960s, has become burdened with ICSR duplication and replication and can result in a fragmented understanding of product safety profiles. For this article, we have defined duplication as multiple representations of the same case within the same database and replication as various representations of the same case across numerous databases. Evolving safety regulations and increasing case volumes signal a need for a new path forward that is sustainable and enhances public health. While there is no question that ICSRs are a crucial component of safety surveillance, stakeholders must evaluate their management to ensure they are fit for purpose in a modern ecosystem. This article aims to embark on that path by proposing a conceptual decentralized ICSR management model to facilitate multi-stakeholder collaboration around new working models to mitigate duplication and replication, allow ecosystem stakeholders to access the latest source of truth on demand, facilitate more meaningful safety analysis and interpretation, and ultimately enable a real-time learning healthcare system to improve patient safety and health outcomes. It describes the feasibility analysis results and subsequently conducted proof of concept (PoC) based on a decentralized system architecture supporting such a decentralized model. It outlines considerations, challenges, and opportunities compared with the current state related to case management and signal management processes.

Drug SafetyVol. 48(8)
London School of Hygiene & Tropical Medicine (GB), Gene Therapy Laboratory (FR), Roche (United Kingdom) (GB), GlaxoSmithKline (United States) (US), Université Bourgogne Franche-Comté (FR), AstraZeneca (United States) (US), Astellas Pharma (United States) (US), La Roche College (US), Bayer (Germany) (DE), National Patient Safety Foundation (US)
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi, Merck KGaA
Reduced inequalities
Openalex Percentile: Top 96%
Electronic Health Records Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.